Results 111 to 120 of about 20,823,742 (292)

Virtual screening for NS5B inhibitors of Hepatitis C virus [PDF]

, 2012
Hepatitis C Virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at a risk of developing significant morbidity and mortality.
Achuthsankar S. Nair, Amjesh R, Sugunan V.S.   +2 more
core   +2 more sources

Hepatitis C : an emerging concern [PDF]

, 1997
Hepatitis C has surfaced worldwide as a formidable concern to public health. Recent developments have sharpened methods of serological detectability, epidemiological study and patient treatment.
Falzon, Dennis, Gauci, Charmaine, Mallia Azzopardi, Charles, Portelli, Alfred V.   +3 more
core  

Fulminant hepatic failure (FHF) due to acute hepatitis C [PDF]

, 1969
Bilal Bin Younis, Rozina Arshad, Saima Khurshid, Junaid Masood, Farhan Nazir, Maham Tahira   +5 more
openalex   +1 more source

HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy

BMC Infectious Diseases, 2019
Background The advent of effective direct-acting antivirals (DAAs), has prompted an assessment of the French Hepatitis C virus (HCV) screening strategy, which historically targeted high-risk groups. One of the options put forward is the implementation of
Cécile Brouard, Leïla Saboni, Arnaud Gautier, Stéphane Chevaliez, Delphine Rahib, Jean-Baptiste Richard, Francis Barin, Christine Larsen, Cécile Sommen, Josiane Pillonel, Elisabeth Delarocque-Astagneau, Nathalie Lydié, Florence Lot, the 2016 Health Barometer Group   +13 more
doaj   +1 more source

Hepatitis-C Virus Infection among Injecting Drug Users in Lahore, Pakistan: A Descriptive and Analytical Cross Sectional Study [PDF]

, 1969
Abdul Majeed Akhtar, Sadia Majeed, Muhammad Jamil, Abdul Rehman, Sufia Majeed   +4 more
openalex   +1 more source

The Iowa Viral Hepatitis Strategic Plan 2012-2016, August 26, 2014 [PDF]

, 2014
Since the creation of the first viral hepatitis plan in 2004 several documents and advancements have been released that help Iowa plan and prioritize this revision of our hepatitis plan.

core  

T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells

Frontiers in Immunology
IntroductionThe coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has highlighted the critical importance of understanding protective long-lasting immune responses.
Ulrik Fahnøe, Ulrik Fahnøe, Ulrik Fahnøe, Shan Feng, Shan Feng, Shan Feng, Alexander P. Underwood, Alexander P. Underwood, Alexander P. Underwood, Kivin Jacobsen, Amir Ameri, Thomas H. Blicher, Christina S. Sølund, Christina S. Sølund, Christina S. Sølund, Brad R. Rosenberg, Liselotte Brix, Nina Weis, Nina Weis, Jens Bukh, Jens Bukh, Jens Bukh   +21 more
doaj   +1 more source

Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection. [PDF]

, 1969
Sobia Hassan, Serajuddaula Syed, Shahnaz Imdad Kehar   +2 more
openalex   +1 more source

Recommendation for Routine Prenatal Screening for Hepatitis C [PDF]

, 2018
Hepatitis C prevalence and incidence are on the rise, both nationally and in Vermont. This project aims to assess the feasibility and potential benefit of implementing routine prenatal Hepatitis C screening, as opposed to screening only patients who fall
Morrison, Althea L
core   +1 more source

Pengaruh Penerapan Universal Precaution (Hand Higiene dan APD) dalam Mencegah Insiden Hepatitis C pada Pasien Hemodialisa di RSU PKU Muhammadiyah YOGYAKARTA [PDF]

, 2015
Background: Hepatitis C is caused by hepatitis C virus (HCV); a small RNA virus which is wrapped by fat, its diameter is around 30 to 60 nm. An acute HCV infection is generally asymptomatic or minimally symptomatic.
Mashuri, M. (Mashuri)
core